American Society of Hematology

SHERPA: Blue

People

  1. Scordo
    Scordo
  2. Shah
    Shah
  3. Giralt
    Giralt
  4. Perales
    Perales
  5. Devlin
    Devlin
  6. Landau
    Landau
  7. Mailankody
    Mailankody
  8. Hultcrantz
    Hultcrantz
  9. Lesokhin
    Lesokhin
  10. Dahi
    Dahi

Groups

  1. Bone Marrow Transplant (145)
  2. CTCR Scholars (145)
  3. Center for Hematologic Malignancies (145)
  4. Department of Medicine (145)
  5. Hematologic Malignancies, Division of (145)
  6. Hematology-Oncology Fellows (145)
  7. Survivorship Research (130)
  8. Epidemiology and Biostatistics (95)
  9. Biostatistics Service (94)
  10. Sloan Kettering Institute Postdocs (81)
Search Within
  1. "Michael Scordo"
Formats
  1. Meeting Abstract (119)
  2. Journal Article (21)
  3. Editorial (2)
  4. Research Letter (2)
  5. Correspondence (1)
Groups
  1. Bone Marrow Transplant (145)
  2. CTCR Scholars (145)
  3. Center for Hematologic Malignancies (145)
  4. Department of Medicine (145)
  5. Hematologic Malignancies, Division of (145)
  6. Hematology-Oncology Fellows (145)

More Groups

People
  1. Michael Scordo (145)
  2. Gunjan Shah (120)
  3. Sergio Giralt (109)
  4. Miguel-Angel Perales (68)
  5. Sean Devlin (63)
  6. Heather Landau (61)

More People

Years
  1. 2025 (3)
  2. 2024 (30)
  3. 2023 (40)
  4. 2022 (20)
  5. 2021 (9)
  6. 2020 (13)

More Years

Publications
  1. Blood (123)
  2. Blood Advances (22)

Results (145)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma
    Journal Article

    Adegbite, B.; Tan, C. R.; Shekarkhand, T.; Firestone, R. S.; Jurgens, E. M.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; Rajeeve, S.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • T-ICAHT: Grading and prognostic impact of thrombocytopenia after CAR T-cell therapy
    Journal Article

    Rejeski, K.; Sanz, J.; Fei, T.; Nair, M. S.; Hashmi, H.; Avigdor, A.; Beyar-Katz, O.; Bücklein, V. L.; Curran, K. J.; Einarsdottir, S.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Restarting teclistamab and talquetamab after prolonged dose delay may not require re–step-up dosing
    Research Letter

    Tan, C. R.; Wang, A.; Nemirovsky, D.; Derkach, A.; Shekarkhand, T.; Hamadeh, I.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed/refractory multiple myeloma
    Meeting Abstract

    Rajeeve, S.; Costa, B. A.; Jurgens, E. M.; Nishimura, N.; Farzana, T.; Firestone, R. S.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Prospective feasibility trial of pharmacokinetic directed melphalan for lymphoma patients undergoing autologous hematopoietic cell transplantation
    Meeting Abstract

    Hughes, C. F. M.; Lin, A.; Bromberg, M.; Devlin, S. M.; Saldia, A.; Engstler, D. E.; Hanley, D. M.; Aremu, Y.; Donach, M.; Hoover, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • CAR T-cell therapy for DLBCL with CNS involvement: Overall safe and effective with limited efficacy in patients with leptomeningeal disease
    Meeting Abstract

    Luttwak, E.; Cassanello, G.; Brown, S.; Devlin, S. M.; Imber, B. S.; Ip, A.; Leslie, L. A.; Accav, N. G.; Beyar-Katz, O.; Corona, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Comparative real-world outcomes of commercial CD19-directed CAR T-cell therapies in large B-cell lymphoma
    Meeting Abstract

    Deschênes-Simard, X.; Bromberg, M.; Devlin, S. M.; Katz, O. B.; Ip, A.; Marcus, R.; Avigdor, A.; Ballweg, A.; Rabinovich, E.; Alhomoud, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Daratumumab versus lenalidomide as maintenance therapy in newly diagnosed multiple myeloma- Interim efficacy results of a randomized clinical trial
    Meeting Abstract

    Rajeeve, S.; Derkach, A.; Devlin, S. M.; Santos, J.; Przemielewska, A.; Sood, T.; Maclachlan, K. H.; Hashmi, H.; Tan, C. R.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A Proof-of-principle of split-course bridging radiotherapy (SC-BRT) prior to CAR T-cell therapies for relapsed or refractory B-cell lymphomas: A phase 1a pilot cohort
    Meeting Abstract

    Imber, B. S.; Brosoff, A.; Roszak, E.; McAvoy, D.; Hosszu, K. K.; Boardman, A. P.; Dahi, P. B.; Shah, G. L.; Scordo, M.; Park, J. H.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • When can we define cure after CAR-T therapy in LBCL? insights from serial landmark analyses
    Meeting Abstract

    Gomez-Llobell, M.; Shouval, R.; Brown, S.; Accav, N. G.; Devlin, S. M.; Corona, M.; Rejeski, K.; Rivas-Delgado, A.; Luna, A.; Luttwak, E.; more...
    Blood (2024)

    Fulltext@MSK | Save